M protein, the major virulence factor of group A streptococci, has antiopsonic activity in that it inhibits activation of the alternative complement pathway on the streptococcal surface. Two properties of M protein have been claimed to account for the inhibitory activity, namely, (i) its binding affinity for complement factor H, which is an inhibitor of alternative pathway activation, and (ii) its high binding affinity for fibrinogen. We have recently shown that fibrinogen, like M protein, inhibits alternative pathway activation by possessing binding affinity for factor H. Here we report that fibrinogen effectively competes with factor H for binding to M protein but retains its own binding affinity for factor H. The presence of fibrinogen did not significantly affect alternative pathway inhibition on the streptococcal surface.
In the absence of specific antibodies, opsonization may occur by activation of the alternative complement pathway (for a review, see reference 15) . It results in covering microorganisms with covalently bound C3 fragments which allow or support uptake by phagocytic cells carrying C3 receptors. The alternative pathway functions through an amplification system driven by particle-bound C3 convertases (C3bBb), labile enzyme complexes which cleave C3, thereby generating reactive C3b and increasing the amount of particle-bound C3b. In solution and on autologous cells, this process is inhibited by factors dissociating the C3bBb complex and rendering C3b accessible to inactivation by factor I. A major control protein of the alternative pathway is factor H, a 150-kDa serum protein, which inhibits soluble C3b and also contributes to the control of C3b that is bound to autologous cells (2, 14) .
M protein is the major virulence factor of group A streptococci. It is a fibrillar surface molecule which protects the bacteria from ingestion and killing by the phagocytic cells of the host (11, 18) . This effect appears to result from a variety of biological activities, which include inhibition of phagocytosis (23) and inhibition of opsonization.
It has previously been shown that M protein may prevent alternative pathway opsonization by facilitating the control of streptococcus-bound C3b by factor H (6, 9) . This effect appeared to be mediated by binding of factor H to M protein (9) .
On the other hand, M protein has long been known to bind fibrinogen with high affinity (10) . It had been shown that this binding reaction essentially contributes to the antiphagocytic activity of M protein, and it was proposed that the underlying mechanism involved complement inhibition (2, (24) (25) (26) (27) . Recently, we have shown that fibrinogen is indeed able to prevent alternative pathway activation (20) . Interestingly, in this regard, fibrinogen resembled M protein in that it also exhibited binding affinity for factor H.
Here we describe an attempt to analyze the interaction between M protein, fibrinogen, and factor H on the strepto-* Corresponding author.
coccal surface and its effect on alternative pathway regulation and opsonization.
MATERUILS AND METHODS
Bacteria. Streptococcus pyogenes D471 carrying the M6 protein and the M-protein-negative strain T28/51/4-4 were from the Rockefeller University collection. Bacteria were grown in Todd-Hewitt broth containing 0.2% yeast extract and killed by overnight incubation in the presence of 50 p,g of mitomycin (Serva) per ml (13) . Bacterial counts were assessed by measuring the pellet volumes after centrifugation at 8,400 x g for 8 min in a routine hematocrit centrifuge. The pellet volumes were standardized by using calibration latex particles (measuring 1.1 pLm in diameter) which were counted in parallel in an electronic particle counter with an orifice tube of 30-pLm diameter (model ZF, Coulter Electronics). Presumably because streptococci form chains, this method was found to be the most reliable and reproducible one when compared with counting in Neubauer chambers, measuring the optical density at 546 nm, and electronic particle counting of the bacteria themselves.
Proteins. M6 protein was isolated from the periplasm of Escherichia coli cloned to contain the streptococcal gene for M6 protein (21) and was purified as described previously (4 as an isolated protein at a concentration in serum of 3.3 x 10-6 M (0.5 mg/ml) in the absence and presence of human fibrinogen at a concentration in plasma of 10-5 M (3.4 mg/ml) and various dilutions thereof. Trace-radiolabeled factor H and 2 x 109 bacteria were used, and after a 30-min incubation on ice, bacterium-bound radioactivity was determined. Shown are median values and the range of six determinations. Experiments with serum and plasma were performed with samples from six apparently healthy individuals.
containing 150 mM NaCl and 0.02% NaN3. For studies of the dissociation of C3bBb complexes, these complexes were formed in Veronal buffer containing 5 mM MgCl2. All other studies were done with phosphate-buffered saline.
Since activation of the alternative pathway requires magnesium but not calcium, it is possible, by the addition of 12.5 mM magnesium to plasma chelated with 10 mM EGTA [ethylene glycol-bis(3-aminoethyl ether)-NN,N',N'-tetraacetic acid] to completely reconstitute alternative pathway activity without activation of the coagulation system. Dissociation of particle-bound C3bBb. Soluble and, subsequently, particle-bound, nickel-stabilized C3bBb enzymes were used to generate and deposit reactive C3b as described previously (8, 9) . Particle-bound C3bBb complexes were formed in the presence of 5 mM magnesium by using radiolabeled factor B, and the dissociation of the labeled Bb fragment from particle-bound C3b was measured over time (7, 9) .
Protein binding studies. Protein binding to streptococci was measured and evaluated as described previously (9) . Briefly, trace-radiolabeled proteins were incubated with the bacteria, and the bacterium-bound fraction was separated from the soluble one by centrifugation of the sample through 20% sucrose.
Binding between proteins in solution was determined by using chemical cross-linking with di-thio-bis-succinimidylpropionic acid (DSP; Pierce) as described previously (19, 20) . Briefly, 0.36 ,ug (2 x 10-7 M) of 125I-labeled factor H, corresponding to 0.26 ,Ci in the presence of 3.3 x 10-6 M albumin, was incubated in a final volume of 12 ,ul of phosphate-buffered saline (pH 7.5) together with fibrinogen or M protein or both (all at 3.3 x 10-6 M). After 20 min of incubation at room temperature, DSP dissolved in dimethyl sulfoxide (Sigma) was added to a final concentration of 2 ,uM, and incubation was continued for 30 min. The reaction was stopped by the addition of sample buffer for sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Opsonization studies. In 1 ml of 50% serum or plasma in phosphate-buffered saline containing 106 cpm of 12'I-labeled C3 and 12.5 mM Mg2+-10 mM EGTA or -20 mM EDTA, 2
x 109 streptococci were incubated at 37°C for 60 min, pelleted, resuspended in 100 p,l of supernatant, and centrifuged through 20% sucrose. Radioactivity was counted in pellets and total supernatants to quantitate bound C3 products.
RESULTS
Binding of factor H to streptococci in serum and plasma and in the presence of isolated fibrinogen. When streptococci were incubated in serum containing trace-radiolabeled factor H, M+ bacteria were found to bind approximately 5% of the radioactivity. The addition of EDTA to serum did not significantly influence the binding reaction. Thus, factor H binding could be examined in plasma for comparison. In the presence of EDTA, M+ streptococci bound 5.8% of factor H in serum and 1% in undiluted plasma (Fig. 1) . Uptake by Mstreptococci was 0.3 and 0.5% in serum and undiluted plasma, respectively. Experiments with purified proteins showed that isolated fibrinogen had an effect similar to that of plasma. The addition of fibrinogen at the physiologic concentration of 10-5 M (3.4 mg/ml) resulted in a decrease of factor H binding to M+ streptococci from 6.6 to 1.9%. This was a reduction to 22% if one considers the binding to Mstreptococci as background, which was 0.8 and 0.6%, respectively, for factor H alone and with fibrinogen added.
Inhibition of factor H binding by fibrinogen was studied in greater detail. Purified fibrinogen at the concentration in plasma of 10-5 M substantially reduced the specific binding of isolated factor H to M+ streptococci but only marginally affected the low binding of factor H to M-bacteria (Fig. 2) . The binding to M+ streptococci was subjected to Scatchard analysis, considering as background the binding of factor H to M-bacteria (Fig. 3) . For M+ streptococci of strain D471 used in the experiments, the average number of binding sites for factor H was found to be 6,700 per organism. In the presence of fibrinogen, the data showed considerable variability, which could not be reduced by repeating the experiment. With fibrinogen present, the number of binding sites for factor H appeared to be reduced to approximately 1,100, i.e., to less than one-fifth that without fibrinogen. The dissociation constants were calculated to be 3.5 x 10-6 M in the absence of fibrinogen and 6 x 10-6 M in its presence.
Binding of fibrinogen to streptococci in the presence of factor H. In contrast to the effects of fibrinogen on 500,000. In addition, factor H, fibrinogen, and M protein together form a complex migrating at an Mr which appears slightly larger than that of the factor H-fibrinogen complex (i.e., 500,000). Since this experiment was performed at an equimolar concentration of M protein and fibrinogen, which had previously been shown to complex more than 85% of fibrinogen molecules (26) , it can be concluded that a threemolecule complex, consisting of M protein, fibrinogen, and factor H, had formed.
Dissociation of streptococcus-bound C3bBb by factor H in the presence of fibrinogen. With regard to the apparent complexity of the interaction taking place between M pro- bound fibrinogen [ tein, fibrinogen, and factor H, it was of interest to study the influence of fibrinogen on the activity of factor H in the control of streptococcus-bound C3bBb. The C3bBb complex was generated by using streptococcus-bound C3b and radiolabeled factor B, which was cleaved by the addition of factor D, and the time course of the decay of radiolabeled Bb from the surface-bound subunit C3b was measured. One set of experiments was performed with whole serum and plasma. To obtain factor H activities low enough to be assessed experimentally, the samples had to be diluted more than 100-fold, which resulted in a corresponding reduction in the fibrinogen concentration in the plasma samples. No difference in decay-accelerating activities was observed between serum and plasma (Fig. 7) .
Purified proteins were used to assess the effect of fibrinogen at higher concentrations. The results showed that the activity of factor H in accelerating the decay of streptococcus-bound C3bBb was not affected by fibrinogen present at the concentration in plasma of 10-' M, which is a 5,000-fold molar excess over the concentration of factor H applied (Fig.   7 ). Fibrinogen alone had no effect on the stability of the C3bBb complex.
Opsonization studies. In light of these results, it was decided to repeat previous studies (2, 24) and to compare again the antiopsonic activities of M protein in plasma and serum.
To prevent clotting of the plasma samples and classical pathway activation, opsonization via the alternative pathway was determined in the presence of Mg-EGTA. After the addition of radiolabeled C3, the binding of radioactivity to M' and M-streptococci was measured. We found that in both plasma and serum, uptake of C3 was substantially lower on M' streptococci than on M-streptococci (Fig. 8) . Comparing C3 deposition on M' streptococci in serum with that in plasma, it was found that the presence of fibrinogen further reduced alternative pathway opsonization of M' 
DISCUSSION
When M+ streptococci come into contact with blood, two plasma components, fibrinogen and factor H, apparently compete for binding to M protein exposed on the bacterial surface. Since the affinity of M protein for fibrinogen is at least 10-fold higher than its affinity for factor H and both proteins are present in plasma in similar molar concentrations, fibrinogen is the predominant ligand.
In the present study, the dissociation constant between M protein and fibrinogen was determined to be 1.2 x 10' M.
This number may represent the high-capacity, low-affinity binding described by Whitnack and Beachey (26) . These investigators had concentrated on high-affinity binding with a dissociation constant of 1 x 10' to 5 x 10-9 M, determined by using fibrinogen concentrations between 1 x 10-9
and 2 x 10-8 M. In contrast, the present study was limited to fibrinogen concentrations close to the concentration in plasma of 10-5 M, therefore describing the binding reaction at higher saturation and lower affinity than that described earlier. (3, 8) . It has previously been shown that this increase may result from a low-affinity interaction between factor H and the surface to which C3b is bound (3, 14) . In those experiments, it was sialic acid which, as a surface moiety, rendered bound C3b accessible to inhibition, and this inhibition was mediated by a low-affinity interaction between sialic acid and factor H. The studies with sialic acid also showed that such an interaction may be difficult to identify experimentally (14) .
The studies presented here provide evidence that the situation on the streptococcal surface may be more complex than previously believed. Whereas the analysis of C3bBb stability on M+ streptococci suggests that fibrinogen did not affect the ability of factor H to inhibit alternative pathway activation, global opsonization assays performed with whole serum and plasma show that fibrinogen, to a certain extent, enhanced alternative pathway inhibition. This apparent discrepancy may indicate that complement regulatory events which have not been addressed in the regulation studies could be affected by fibrinogen, which might, for instance, interfere with the stabilization of C3bBb complexes by properdin (15) . Alternatively, the discrepancy might be explained by a lack of sensitivity of the C3bBb dissociation assay to reveal a minor positive effect of fibrinogen on the inhibitory function of factor H, which may become significant in the subtle balance of complement regulation in whole serum and plasma.
By using similarly global opsonization assays, previous investigations found that M protein exhibited complement inhibitory activity exclusively in plasma and not in serum (2, 24) . These findings differ from ours, which show only a minor variation between the activities in plasma and serum. The difference between the previous and present results might be explained by relating the effect of fibrinogen to the density of M protein molecules expressed on the streptococcal surface. Because of its elongated structure, fibrinogen, upon binding to an M protein, might enlarge the radius of complement inhibitory activity around the individual M protein molecule. Thereby, fibrinogen might fill gaps between M protein molecules in a situation in which the density of the M protein molecules on the streptococcal surface is relatively low. Electron micrographs presented by Whitnack and Beachey indeed support this assumption of fibrinogen filling gaps in the M protein coat (26) . In this case, the effect of fibrinogen on alternative pathway inhibition would be less pronounced or absent if the number of M protein molecules per streptococcus was so high that surface coverage by M protein was virtually complete. This might indeed be the situation in vivo, where selective mechanisms result in high expression of the virulence factor (1) .
In summary, the effect of fibrinogen on the antiopsonic activity of the streptococcal M protein appears to be small or neutral. Therefore, the role of fibrinogen binding in the antiphagocytic activity of M protein remains speculative. Recently, it was found that fibrinogen has a certain binding affinity for the iC3b receptor of phagocytes (28) . Accordingly, M protein-bound fibrinogen might contribute to the total antiphagocytic activity of the streptococcal surface by occupying and thus blocking this phagocytic receptor.
